Search results
Sabrina Carpenter Used This Skin Therapy Wand for the Met Gala
US Weekly· 21 hours agoWhen it comes to the Met Gala, many of Us talk about what celebrities are wearing on the Met steps...
Black Boy, 12, Is 1st Person Ever To Receive Groundbreaking Sickle Cell Gene Therapy Treatment
Black America Web· 2 days agoLast Wednesday, Kendric Cromer, a 12-year-old Black patient from the suburbs of Washington, D.C.,...
Earnings call: ATI Physical Therapy sees revenue climb in Q1 2024 By Investing.com
Investing.com· 2 days agoATI Physical Therapy (Ticker: ATIP) has reported a solid start to 2024, with an 8.7% increase in net...
The Inventor of the Chatbot Tried to Warn Us About A.I.
The New Republic via Yahoo News· 21 hours agoThe book is dotted with equations and scraps of code, almost as if he were working out some thoughts...
Bluebird, Vertex prep for first commercial use of sickle cell gene therapies
BioPharma Dive via Yahoo Finance· 3 days agoVertex, meanwhile, said there are currently 25 centers set up to administer Casgevy across the...
Can Japanese Toji Water Therapy Help You Live Longer?
Eat This, Not That! via AOL· 2 days agoMost people dream of living a long, healthy, and happy life. Several factors can contribute to...
ATI Physical Therapy Inc (ATIP) (Q1 2024) Earnings Call Transcript Highlights: Steady Growth ...
GuruFocus.com via Yahoo Finance· 2 days agoATI Physical Therapy Inc (ATIP) showcases robust revenue growth and operational advancements in the first quarter of 2024, setting a positive trajectory for the upcoming quarters.
AstraZeneca ups stake in Cellectis in latest cell therapy bet
BioPharma Dive via Yahoo Finance· 3 days agoThe British drugmaker, which has made genetic medicine a larger priority of late, added $140 million...
Isto Biologics Unveils Fibrant Liberty(TM): An Advanced Allograft Solution Designed for Rapid and...
Digital Journal· 11 hours agoAbout Isto Biologics Isto Biologics is a leading biologics and cellular therapy company. Focused on Helping Patients Heal Faster™ through innovative solutions for bone regeneration ...
Loss-Making Travere Therapeutics, Inc. (NASDAQ:TVTX) Expected To Breakeven In The Medium-Term
Simply Wall St. via Yahoo Finance· 20 hours agoBefore we wrap up, there’s one issue worth mentioning. Travere Therapeutics currently has a...